RxDoctor Payments Data

Samuel Washington, MD

Urology · San Francisco, CANPI 1275890055

Payments from drug & device makers

$3,155in general payments, 2019–2025

Across 9 payments — averaging $350.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$3K
  • Johnson & Johnson$140
  • Teleflex LLC$40
  • Amgen$32
  • Janssen Scientific Affairs, LLC$32
  • Pfizer$32
  • plus $30 from 1 others

What the payments were for

  • Speaking & faculty fees$2,76588%
  • Food & beverage$30510%
  • Education$853%

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,155 in reported general payments places this provider in the 50th percentile of 1,324 urology providers in California.

See all urology providers in California

Medicare billing

Part B allowed, 2024
$91,545
Medicare patients
312
Services billed
858

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxybutynin Chloride16$341
Finasteride18$206
Tamsulosin Hcl17$158

Paid to pharmacies, not to this prescriber.

Other urology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →